Rockefeller Capital Management
PLXP

Rockefeller Capital Management’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

Rockefeller Capital Management’s Portfolio PLXP Stock Details PLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-3,000
Closed – – 4183
2022
Q4 		$0 Hold
3,000
– – ﹤0.01% 4348
2022
Q3 		$1K Hold
3,000
– – ﹤0.01% 3822
2022
Q2 		$7K Hold
3,000
– – ﹤0.01% 3333
2022
Q1 		$12K Buy
3,000
+500
+20% +$2.74K ﹤0.01% 2973
2021
Q4 		$20K Buy
+2,500
New +$29.3K ﹤0.01% 2658

Other funds holding PLXP

PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GSC
Ground Swell Capital Folly Beach, South Carolina $50.7M AUM 30.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return
SF
Synovus Financial Columbus, Georgia $8.74B AUM 12.78% 1-Year Est. Return

Rockefeller Capital Management's PLXP Position: Q1 2023 in Review

Rockefeller Capital Management sold out of PLx Pharma Inc. Common Stock (PLXP) in Q1 2023, closing a stake of 3,000 shares.

Rockefeller Capital Management first reported a position in PLXP in Q4 2021 and held it in 5 quarters. The position peaked at $20K in Q4 2021. 34 funds tracked by Wall St. Rank hold PLXP as of Q1 2023.

  • Rockefeller Capital Management reported no remaining PLx Pharma Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Rockefeller Capital Management sold 3,000 PLx Pharma Inc. Common Stock shares in Q1 2023.
  • Rockefeller Capital Management first reported a position in PLx Pharma Inc. Common Stock in Q4 2021 and held it in 5 quarters.
  • Rockefeller Capital Management's PLx Pharma Inc. Common Stock position peaked at $20K in Q4 2021.
  • 34 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q1 2023.

Based on Rockefeller Capital Management's 13F filing for Q1 2023, filed 16 May 2023.